Ayala Pharmaceuticals, Inc. (AYLA) has 7 open-market insider trades by 6 insiders since 2020. The most active filer is Roni Mamluk, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| aMoon 2 Fund Limited Partnership | 10% Owner | — | 1 | $12.0M | 2020-05-12 |
| Harel Insurance Investments & Financial Services Ltd. | 10% Owner | — | 1 | $8.3M | 2020-05-12 |
| Israel Biotech Fund I, L.P. | 10% Owner | — | 1 | $3.4M | 2020-05-12 |
| Roni Mamluk | CEOPres | — | 2 | $910K | 2023-01-19 |
| Gary B. Gordon | — | — | 1 | $52K | 2023-01-19 |
| David Sidransky | Dir | — | 1 | $4K | 2023-01-19 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Gary B. Gordon | — | Sell | $52K | 2021-02-24 |
| Roni Mamluk | CEO & President | Sell | $933K | 2021-02-22 |
| Gary B. Gordon | Chief Medical Officer | Sell | $45K | 2021-01-20 |
| Roni Mamluk | CEO & President | Sell | $606K | 2021-01-20 |
| Harel Insurance Investments & Financial Services Ltd. | 10% Owner | Buy | $8.3M | 2020-05-12 |
| Israel Biotech Fund I, L.P. | 10% Owner | Buy | $3.4M |
Companies that share insiders with AYLA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2020-05-12 |
| aMoon 2 Fund Limited Partnership | 10% Owner | Buy | $12.0M | 2020-05-12 |
| David Sidransky | Director | Buy | $4K | 2020-05-08 |